The behavior of migraine in patients with Parkinson's disease

被引:6
作者
Vilaca, Celmir de Oliveira [1 ]
Araujo Leite, Marco Antonio [1 ]
de Souza, Jano Alves [2 ]
Orsini, Marco [1 ,2 ,3 ]
Pereira, Joao Santos [4 ]
Amaral, Clayton [1 ,2 ]
机构
[1] Univ Fed Fluminense, Div Neurol, Movement Disorders Unit, BR-24220000 Niteroi, RJ, Brazil
[2] Univ Fed Fluminense, Headache Res Sect, Antonio Pedro Univ Hosp, BR-24220000 Niteroi, RJ, Brazil
[3] Severino Sombra Univ Ctr, Dept Med, Vassouras, RJ, Brazil
[4] Hosp Univ Pedro Ernesto, State Univ Rio de Janeiro, Neurol Serv, Movement Disorders Sect, Rio De Janeiro, Brazil
关键词
Parkinson's disease; migraine; dopamine;
D O I
10.4081/ni.2015.6133
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Parkinson's disease (PD) is characterized by the degeneration of dopaminergic systems in the central nervous system. In migraine it is supposed to occur hyperactivation of central dopaminergic pathways. We verified the hypothesis of improved migraine in patients who manifest PD. We evaluated 109 patients with PD over 40 years (57 men and 52 women) about the presence throughout the life of migraine, as well as the possibility of improvement in migraine after the onset of motor symptoms of PD. This group was compared to a control group of 152 people (41 men and 152 women) without PD regarding the presence of migraine and its improvement. Twenty-one patients manifested migraine in the group with PD (16 women and 5 men) in which 13 reported improvement in migraine after the onset of symptoms of PD. Among the controls, 37 interviewed had migraine history (32 women and 5 men) among which 20 showed improvement. There was no significant difference when comparing the two groups (chi(2)(1:0,05)=0.337; P<0.382). We were unable to relate the improvement of migraine with the emergence of PD motor signs, despite the degeneration of dopaminergic pathways of the central nervous system.
引用
收藏
页码:66 / 69
页数:4
相关论文
共 30 条
  • [21] Diagnosis and initial management of Parkinson's disease
    Nutt, JG
    Wooten, GF
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (10) : 1021 - 1027
  • [22] Cognitive impairment and dementia in Parkinson's disease
    Pagonabarraga, Javier
    Kulisevsky, Jaime
    [J]. NEUROBIOLOGY OF DISEASE, 2012, 46 (03) : 590 - 596
  • [23] Palmas MA, 2000, J HEADACHE PAIN, V1, pS153
  • [24] Dopamine and migraine
    Peroutka, SJ
    [J]. NEUROLOGY, 1997, 49 (03) : 650 - 656
  • [25] Clinical susceptibility to migraine with aura is modified by dopamine D-2 receptor (DRD2) NcoI alleles
    Peroutka, SJ
    Wilhoit, T
    Jones, K
    [J]. NEUROLOGY, 1997, 49 (01) : 201 - 206
  • [26] A nationwide population-based study of migraine in Brazil
    Queiroz, L. P.
    Peres, M. F. P.
    Piovesan, E. J.
    Kowacs, F.
    Ciciarelli, M. C.
    Souza, J. A.
    Zukerman, E.
    [J]. CEPHALALGIA, 2009, 29 (06) : 642 - 649
  • [27] Epidemiology and Cultural Differences in Tension-Type Headache
    Sahler, Kristen
    [J]. CURRENT PAIN AND HEADACHE REPORTS, 2012, 16 (06) : 525 - 532
  • [28] Migraine pathophysiology and its clinical implications
    Silberstein, SD
    [J]. CEPHALALGIA, 2004, 24 : 2 - 7
  • [29] VANHILTEN JJ, 1992, CLIN NEUROL NEUROSUR, V94, pS168
  • [30] Dopamine and retinal function
    Witkovsky, P
    [J]. DOCUMENTA OPHTHALMOLOGICA, 2004, 108 (01) : 17 - 40